Tim Welsh of Nexus Strategy likes to call Tom Giachetti the only “celebrity securities attorney,” but Giachetti himself said he “never wanted to be a lawyer. Instead, he said he “wanted to be in the investment business.” So armed with a law degree and a master’s in economics, he first clerked for a federal judge for a year before going into investment banking in the mid-1980s. That’s where he had a client who lost $1 million at a large wirehouse. He contacted that brokerage firm on behalf of that New Jersey-based client and, without resorting to arbitration, Giachetti “got all his money back,” before he “started suing the wirehouses.”
Having some success, he found that many broker-dealers, including some wirehouses, “started calling on me” for their legal business, but Giachetti’s true entrée into becoming the most well-respected securities attorney in the advisory business, which more than qualifies him to be honored as a member of the IA 25 for 2014, began after Schwab Advisor Services asked him to review a legal matter for a Schwab client. That request led to a speech he presented at a Schwab Impact conference in San Francisco in 1991. Coming into prominence as the RIA industry began to grow in the late 1980s, Giachetti said his career focus on advisors “just ballooned; I was the right person in the right place at the right time,” taking his “background and knowledge to grow a business.”
10 Best Stocks To Invest In Right Now: Synthesis Energy Systems Inc.(SYMX)
Synthesis Energy Systems, Inc., a global energy and gasification technology company, provides products and solutions to the energy and chemical industries. It offers technology and equipment in regions, where low rank coals and biomass feed stocks can be converted into high value products through its proprietary U-GAS fluidized bed gasification technology. The company licenses its U-GAS technology rights to third parties and delivers an engineered technology package, as well as provides proprietary equipment components to customers, who have contracted to own and operate projects. It has a joint venture agreement with Shandong Hai Hua Coal and Chemical Company Ltd. for developing, constructing, and operating a syngas production plant utilizing the U-GAS technology in Zao Zhuang City, China; and for producing and selling syngas, and various byproducts of the plant, including ash and elemental sulphur. The syngas can be used as a fuel gas in industrial applications, or can b e used to produce power, synthetic natural gas, methanol, dimethyl ether, glycol, ammonia, direct reduction iron, and synthetic gasoline, as well as other transportation fuels, steam, sulphur, carbon dioxide, or ash. Synthesis Energy Systems, Inc. was founded in 2003 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Lisa Levin]
Synthesis Energy Systems (NASDAQ: SYMX) shares jumped 26.01% to $2.18 on the receipt of a 20-year business license for China Clean Coal Gasification joint venture
- [By Charley Blaine]
Synthesis Energy Systems Inc. (NASDAQ: SYMX) shares were among the Friday’s biggest percentage gainers, all because it has a deal to become a leader in the clean coal gasification market in China.
- [By Roberto Pedone]
One under-$10 specialty chemicals player that's starting to move within range of triggering a major breakout trade is Synthesis Energy Systems (SYMX), which provides various proprietary gasification technology systems and solutions to the energy and chemical industries worldwide. This stock is off to a red hot start so far in 2014, with shares up a whopping 191%.
If you glance at the chart for Synthesis Energy Systems, you'll see that this stock has been uptrending over the last month and change, with shares moving higher from its low of $1.39 to its recent high of $1.85 a share. During that uptrend, shares of SYMX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has started to push shares of SYMX within range of triggering a major breakout trade above some key near-term overhead resistance levels.
Traders should now look for long-biased trades in SYMX if it manages to break out above some near-term overhead resistance levels at $1.85 to $1.86 a share and then once it takes out more key overhead resistance levels at $1.93 to $2 and $2.09 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 594,782 shares. If that breakout gets underway soon, then SYMX will set up to re-test or possibly take out its next major overhead resistance levels at $2.44 to its 52-week high at $2.49 a share. Any high-volume move above those levels will then give SYMX a chance to tag $3 to $3.50 a share.
Traders can look to buy SYMX off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $1.60 to $1.55 a share. One can also buy SYMX off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Heal Care Companies To Invest In 2014: United States Gasoline Fund LP (UGA)
United States Gasoline Fund, LP (UGA) is a commodity pool that issues limited partnership interests (units). The investment objective of UGA is for the changes in percentage terms of its units��net asset value (NAV) to reflect the changes in percentage terms of the spot price of gasoline (also known as reformulated gasoline blendstock for oxygen blending (RBOB)) for delivery to the New York harbor, as measured by the changes in the price of the futures contract for gasoline traded on the New York Mercantile Exchange (the NYMEX) that is the near month contract to expire, except when the near month contract is within two weeks of expiration, in which case the futures contract will be the next month contract to expire, less UGA�� expenses. UGA seeks to achieve its investment objective by investing in a mix of Futures Contracts and Other Gasoline-Related Investments. United States Commodity Funds LLC (USCF) is the general partner of UGA and is responsible for the management of UGA.
The net assets of UGA consist primarily of investments in futures contracts for gasoline, but may also consist of investment contracts for other types of gasoline, crude oil, heating oil, natural gas and other petroleum-based fuels that are traded on the NYMEX, ICE Futures or other United States and foreign exchanges (collectively, Futures Contracts). UGA may also invest in other gasoline-related investments, such as cash-settled options on Futures Contracts, forward contracts for gasoline, cleared swap contracts and over-the-counter transactions that are based on the price of gasoline, crude oil and other petroleum-based fuels, Futures Contracts and indices based on the foregoing (collectively, Other Gasoline-Related Investments).
Advisors' Opinion:- [By Paul Ausick]
The United States Gasoline ETF (NYSEMKT: UGA) is down about 0.7%, at $60.48, in a 52-week range of $53.35 to $65.86.
The United States Brent Oil ETF (NYSEMKT: BNO) is up less than 0.1%, at $44.38 in a 52-week range of $36.88 to $45.05. The annual high was also set today.
- [By Paul Ausick]
The United States Gasoline ETF (NYSEMKT: UGA) is up about 0.9%, at $62.75 in a 52-week range of $53.35 to $65.86.
The United States Brent Oil ETF (NYSEMKT: BNO) is up 1.5%, at $89.43 in a 52-week range of $73.76 to $89.43. The annual high also was�set today.
Top 10 Heal Care Companies To Invest In 2014: CombiMatrix Corporation(CBMX)
CombiMatrix Corporation, a molecular diagnostics company, operates primarily in the fields of genetic analysis and molecular diagnostics in the United States. The company, through its wholly owned subsidiary, CombiMatrix Diagnostics, operates a diagnostics reference laboratory that provides DNA-based clinical diagnostic testing services to physicians, hospitals, and other laboratories in two primary areas, including prenatal and postnatal developmental disorders, and oncology. It offers a suite of developmental disorder array tests on the prenatal and postnatal application of array-comparative genomic hybridization in diagnosing genomic syndromes associated with developmental delays, autism spectrum disorders, dysmorphic features, and/or birth defects. The company also provides DNAarray?Heme Profile test to address various common hematological malignancies, including chronic lymphocytic leukemia; DNAarray?HER2 PRO test for breast cancer; and DNAarray?Tumor Profile test for the analysis of solid tumors, including breast, colon, lung, prostate, and brain tumors. In addition, it focuses on developing a series of drug compounds to address various oncology-related diseases. CombiMatrix Corporation was founded in 1995 and is based in Irvine, California.
Advisors' Opinion:- [By Wallace Witkowski]
Also, shares of Combimatrix Corp. (CBMX) rose 7.5% to $2.73 in moderate volume late Friday following a Securities and Exchange Commission filing showing Longwood Capital Partners acquired a 5.1% stake in the microcap molecular diagnostics company.
Top 10 Heal Care Companies To Invest In 2014: Ur Energy Inc(URG)
Ur-Energy Inc., an exploration stage junior mining company, engages in the identification, acquisition, evaluation, exploration, and development of uranium mineral properties. The company has 13 projects located in Wyoming and Nebraska, the United States; and 3 exploration projects located in the Northwest Territories and Nunavut, Canada. Its landholdings cover approximately 90,000 acres in the United States and approximately 140,000 acres in Canada. The company was founded in 2004 and is headquartered in Littleton, Colorado.
Advisors' Opinion:- [By The Energy Report]
JH: There are several companies that are in production that we follow in the U.S., such as Cameco Corp. (CCJ). Cameco produces at the Smith Ranch-Highland in the Powder River Basin. There's Uranium One, also in the Powder River Basin. There's Uranium Energy Corp. (UEC). A few near-term producers are rapidly coming online. Ur-Energy Inc. (URG) is one company we like in Wyoming.
- [By John Udovich]
Since the start of the week, small cap nuclear fuel stock USEC Inc (NYSE: USU) more than doubled for investors, something that has not happened for investors in uranium stocks like Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc. (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ). To recap: USEC Inc closed at the $6 level on Friday, but then it surged to the $15 level on Monday only to open at the $10 level on Tuesday when it ultimately closed at $12.46. So what in the world is going on with USEC Inc and is it time to revisit nuclear fuel and uranium stocks?
- [By Bryan Murphy]
If you listened to my bullish calls from December 27th and/or February 24th about Uranerz Energy Corp. (NYSEMKT:URZ), Uranium Resources, Inc. (NASDAQ:URRE), and Ur-Energy Inc. (NYSEMKT:URG), then congratulations - you're now up as much as 50%, depending on when you stepped into a trade, and which stock you chose. Now get out. See, as well as URZ and URG have done and are doing (URRE not so much), it looks like the short-term rally I first spotted a little more than a couple of months ago has fully run its course, and now these names are setting up a pullback.
- [By The Energy Report]
DS: Two of our top picks are Cameco Corp. (CCJ) and Ur-Energy Inc. (URG). For Cameco, we've got a $25/share target and an outperform rating. This company is the industry's go-to, the blue chip uranium company. It's organically growing very low-cost operations, which are for the most part in very safe jurisdictions. It has a lower-risk approach to contracts, with a targeted pricing mix of about 40% fixed-pricing and 60% market-related pricing in the contract book. The company's got a solid balance sheet. We think it's going to end Q3/13 with about $800M in working capital and another $2 billion [$2B] in undrawn lines of credit. It's also diversified across the nuclear fuel chain, with exposure not only to its core uranium mining business but also with nuclear fuel services, like conversion and fuel fabrication. It's got a stake in the Bruce nuclear power plant as well as a newly bolted-on uranium trading business, so it's quite diversified. On top of that, Cameco pays a 2% dividend. We think it offers a very attractive risk/reward proposition at these levels.
Top 10 Heal Care Companies To Invest In 2014: AcelRx Pharmaceuticals Inc.(ACRX)
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.
Advisors' Opinion:- [By Sean Williams]
AcelRx Pharmaceuticals (NASDAQ: ACRX ) received a nice boost from Jefferies this week, after an analyst there initiated coverage on the company with a "buy" rating and a price target of $8, implying about 33% upside from Friday's close. The covering analyst, Corey Davis, is forecasting that AcelRx's post-operative pain management drug/system, sufentanil NanoTab PCA -- which allows patients to give themselves a pre-set dose of sufentanil under their tongue instead of intravenously -- will be approved by the FDA in 2014 and become up to a $400 million drug in the United States. AcelRx's delivery system does drastically reduce the potential for infections and dosing errors, but I always remain concerned when pain medication systems go before the FDA. In essence, I'd still tread cautiously around this story.
- [By Roberto Pedone]
One stock that's starting to trend within range of triggering a near-term breakout trade is AcelRx Pharmaceuticals (ACRX), which is involved in the development and commercialization of therapies for the treatment of acute and breakthrough pain. This stock has been on fire so far in 2013, with shares up big by 150%.
If you take a look at the chart for AcelRx Pharmaceuticals, you'll notice that this stock has been uptrending modestly for the last month and change, with shares moving higher from its low of $8.94 to its recent high of $11.52 a share. During that uptrend, shares of ACRX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ACRX within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in ACRX if it manages to break out above some near-term overhead resistance levels at $11.36 to $11.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 635,439 shares. If that breakout hits soon, then ACRX will set up to re-test or possibly take out its next major overhead resistance levels at $12.50 to its all-time high at $13.50 a share. Any high-volume move above $13.50 will then give ACRX a chance to tag $15 a share.
Traders can look to buy ACRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $10.35 to $10 a share. One can also buy ACRX off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Eric Volkman]
AcelRx (NASDAQ: ACRX ) has slapped a price tag on its recently announced common stock offering. The company's shares will be sold to the market in an underwritten public flotation at a cost of $11.65 apiece. The firm has also granted its underwriters a 30-day purchase option for up to an additional 570,000 shares.
- [By Sean Williams]
The good
Heralding the charge higher was AcelRx Pharmaceuticals (NASDAQ: ACRX ) which advanced 18% on the week after disclosing on Tuesday that its post-operative pain management system, Sufentanil NanoTab PCA, met its primary endpoint in late-stage trials and reconfirmed all previous late-stage study results. This data is strong enough for AcelRx to seek approval from the Food and Drug Administration with a new drug application filing expected next quarter. I'd be cautious with AcelRx moving forward, as the possibility of an FDA rejection for opioid-based treatments is always a possibility.
Top 10 Heal Care Companies To Invest In 2014: Fresh Del Monte Produce Inc.(FDP)
Fresh Del Monte Produce Inc., through its subsidiaries, produces, transports, sources, markets, and distributes fresh and fresh-cut fruit and vegetables worldwide. It also offers prepared fruit and vegetables, juices, beverages, snacks, and poultry and meat products. The company provides various fresh-cut fruit products, such as bananas, pineapples, melons, tomatoes, grapes, apples, pears, peaches, plums, nectarines, cherries, citrus, avocados, blueberries, kiwi, strawberries, plantains, mangos, and fruit cocktail; and fresh-cut vegetable products primarily consisting of potatoes, onions, bell peppers, and cucumbers, as well as prepared salads, such as coleslaw and potato salad. In addition, Fresh Del Monte Produce engages in ocean freight; and manufacture of plastics and box products comprising bins, trays, bags, and boxes. It offers fresh produce under the DEL MONTE, UTC, and Rosy brands; and prepared fruits and vegetables, juices, beverages, and snacks under the DEL MON TE, Fruit Express, Just Juice, and Fruitini brands. The company markets and distributes its products to retail stores, food clubs, wholesalers, distributors, and foodservice operators. Fresh Del Monte Produce Inc. was founded in 1886 and is based in George Town, Cayman Islands.
Advisors' Opinion:- [By Lauren Pollock]
Fresh Del Monte Produce Inc.(FDP) said sales rose in the fourth quarter, driven by a surge in its banana business. The company, however, posted a wider net loss due to higher impairment charges and costs.
- [By Jake L'Ecuyer]
Top decliners in the sector included Fresh Del Monte Produce (NYSE: FDP), off 8.8%, and Coca-Cola Company (NYSE: KO), down 3.5%. Shares of Fresh Del Monte tumbled after the company reported weak quarterly earnings.
Top 10 Heal Care Companies To Invest In 2014: Fastenal Company(FAST)
The Company Is Engaged As A Wholesaler And Retailer Of Industrial And Construction Supplies. The Industrial And Construction Supplies Were Grouped Into Ten Product Lines: Fasteners, Tools And EquipmeNt, Cutting Tools And Abrasives, Hydraulics, Pneumatics, Plumbing And Hvac, Material Handling, Storage And Packaging, Janitorial Supplies, Chemicals And Paints, Electrical Supplies, Welding Supplies, Safety Supplies And Metals, Alloys And Materials.
Advisors' Opinion:- [By Shauna O'Brien]
Shares of Fastenal Company (FAST) were down nearly 3% on Wednesday morning after the company reported earnings that fell below analysts’ expectations.�
FAST’s Earnings in Brief
FAST reported Q4 earnings of�$99.23 million, or 33 cents per share, up from $98.72 million, or 32 cents per share, a year ago. Total revenue was�$813.76 million, up from $757.24 last year. On average, analysts expected to see earnings of 34 cents with�$813.25 million in revenue. For FY2013, the company reported�$448.64 million or $1.51 per share in earnings, up from $420.54 million in 2012. Analysts expected to see earnings per share of $1.52. Revenue for the year was $3.33 billion, up from $3.13 billion in 2012. Analysts expected to see revenue of $3.33 billion.FAST’s Dividend Announcement
On Tuesday, FAST declared its next 25 cent quarterly dividend. This dividend will be paid on February 28 to shareholders of record on January 31. The stock will go ex-dividend on January 29.
Stock Performance
Fastenal shares were down $1.27, or 2.63% during pre-market trading
- [By Monica Gerson]
Fastenal Company (NASDAQ: FAST) is estimated to report its Q3 earnings at $0.41 per share on revenue of $862.54 million.
Costco Wholesale (NASDAQ: COST) is expected to report its Q4 earnings at $1.46 per share on revenue of $32.82 billion.
- [By Chris Hill]
In this installment, our analysts discuss four stocks making big moves.�CarMax (NYSE: KMX ) hits an all-time high after fourth-quarter profits rise. PriceSmart (NASDAQ: PSMT ) jumps after the retailer reports better-than-expected results. Fastenal (NASDAQ: FAST ) falls after it reports weaker-than-expected revenues. And 3D Systems (NYSE: DDD ) racks up big gains after one of its competitors gets an upgrade.�
No comments:
Post a Comment